Skip to main content
Advanced Biomed Inc. logo

Advanced Biomed Inc. — Investor Relations & Filings

Ticker · ADVB ISIN · US00752P1049 US Professional, scientific and technical activities
Open in API
Filings indexed 86 across all filing types
Latest filing 2023-07-05 Regulatory Filings
Country US United States of America
Listing US ADVB

About Advanced Biomed Inc.

http://www.advanbiomed.com/

Advanced Biomed Inc. is a company specializing in the research, development, and commercialization of advanced diagnostic systems for precision oncology. The company focuses on developing proprietary microfluidic biochip technologies that integrate semiconductor and biotechnology principles. Its platform provides assay products and services that cover the full spectrum of cancer care, including early screening, detection, diagnosis, staging, and treatment selection. A key technology involves diagnostic devices that capture circulating tumor cells through physical trapping, offering an alternative to traditional antibody-based methods. The company aims to provide rapid and affordable solutions to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2023
Regulatory Filings
2023-07-05 English
Regulatory Filings 2023
Regulatory Filings Classification · 100% confidence The document is a correspondence letter from Advanced Biomed Inc. to the SEC Division of Corporate Finance responding to comments on a Registration Statement on Form S-1 filed May 22, 2023. It discusses amendments to the Registration Statement, responses to SEC staff comments, revisions to disclosures, financial statement restatements, and filing of exhibits. The document is not the Registration Statement itself but a letter addressing SEC comments and amendments. It is a regulatory correspondence related to a securities offering registration, not a financial report, earnings release, or other specific report type. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory correspondence and compliance documents that do not fit other categories.
2023-06-20 English
FORM S-1/A
Capital/Financing Update Classification · 100% confidence The document is an Amendment No. 1 to Form S-1, a registration statement filed with the SEC under the Securities Act of 1933. It is a preliminary prospectus related to the offering and sale of common stock by Advanced Biomed Inc. The document includes detailed disclosures about the company, its regulatory environment, and risks related to its operations in China. Form S-1 and its amendments are filings related to initial public offerings or other securities registrations, which fall under capital raising and financing activities. This is not an annual report, earnings release, or any other financial report but a registration statement amendment for a securities offering. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is the actual filing, not just an announcement or certification.
2023-06-20 English
Regulatory Filings 2023
Regulatory Filings
2023-06-07 English
Regulatory Filings 2023
Regulatory Filings Classification · 95% confidence The document is a detailed correspondence letter from Advanced Biomed Inc. to the SEC Division of Corporate Finance, responding to comments on an Amendment No.1 to Draft Registration Statement on Form S-1. The text includes detailed responses to SEC staff comments regarding disclosures in the Registration Statement, including product development, regulatory approvals, permissions, accounting policies, and business operations. The document references the Registration Statement multiple times and discusses revisions made to it. The Form S-1 is a registration statement used for securities offerings, and this document is a comment letter response, not the registration statement itself. It is a regulatory filing submitted to the SEC as part of the registration process. The document is not an Annual Report, Earnings Release, or any other financial report type. It is a regulatory correspondence related to a securities registration filing. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length (15,000 characters) and content confirm it is not a brief announcement or a report publication announcement but a substantive regulatory filing.
2023-05-20 English
FORM S-1
Regulatory Filings Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, dated May 19, 2023. Form S-1 is a registration statement used by companies planning an initial public offering (IPO) or other securities offering. The text includes detailed disclosures about the company, its business operations, regulatory risks, and the offering process. It is not a financial report like an annual or quarterly report, nor is it an earnings release or management discussion. It is a regulatory filing related to securities registration and offering. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement and does not fit into other specific categories like capital/financing update or proxy solicitation.
2023-05-20 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.